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ABSTRACT
Genome projects are approaching completion and are saturating sequence databases. This paper
discusses the role of the two-hybrid system as a generator of hypotheses. Apart from this rather
exhaustive, financially and labour intensive procedure, more refined functional studies can be
undertaken. Indeed, by making hybrids of two-hybrid systems, customised approaches can be developed
in order to attack specific function-related problems. For example, one could set-up a “differential”
screen by combining a forward and a reverse approach in a three-hybrid set-up. Another very interesting
project is the use of peptide libraries in two-hybrid approaches. This could enable the identification of
peptides with very high specificity comparable to “real” antibodies. With the technology available, the
only limitation is imagination.
INTRODUCTION
Protein-protein interactions
Protein-protein interactions are intrinsic to virtually every cellular process ranging from DNA
replication, transcription, splicing and translation, to secretion, cell cycle control, intermediary
metabolism, formation of cellular macrostructures and enzymatic complexes. The formation of large
cellular structures such as the cytoskeleton, the nuclear scaffold, and the mitotic spindle result from
complex interactions between proteins. Relatively smaller structures such as nuclear pores, centrosomes
and kinetochores are beginning to be characterized and, in each case, protein-protein interactions seem
to play a crucial role.
Apart from the evident structural requirements provided by a plethora of protein-protein interactions,
there are a large number of transient protein-protein interactions that control and regulate a large
number of cellular processes. All modifications of proteins involve such transient protein-protein
interactions. Indeed kinases, phosphatases, glycosyl transferases, acyl transferases and proteases interact
only transiently, i.e. for a limited period of time, with their protein substrates. Such protein-modifying
enzymes encompass a large number of fundamental processes such as cell growth, the cell cycle,
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metabolic pathways and signal transduction. Surprisingly, very large protein complexes also mediate
many of these enzymatic activities. Transmission of regulatory signals from the external environment to
relevant locations in the cell was originally thought to consist of successive catalytic activities that could
amplify a weak signal into a significant cellular response. However, more recent experiments suggest
that in many signal transduction pathways, the catalytic activities involved, such as protein kinases, may
bind strongly to their protein substrates. In addition, structural proteins required for signal transmission
have been suggested to act as scaffolds, bridging several proteins involved at consecutive steps in a
signal transduction pathway (1). Thus, signal transduction pathways might be considered as large
protein structures through which a signal is being transmitted. A striking example is the formation of the
Death-Inducing Signaling Complex (DISC) at the Fas receptor. Only a few seconds after receptor
triggering, a highly complex mixture of signal transducing molecules is recruited to the intracellular part
of the receptor. This newly formed complex is capable of transmitting multiple specific signals
provoking a highly regulated cellular response (2).
Alteration of protein-protein interactions is known to contribute to many diseases. Hence, the
manipulation of protein-protein interactions that contribute to disease is a potential therapeutic strategy.
Summarising, protein-protein interactions make up biological machines that are like intricate three-
dimensional jigsaw puzzles, forming arrays of interlocking protein components that assemble and
disassemble over time and in response to complex signals.
Tools for the study of protein-protein interactions
The study of protein-protein interactions can be conceptually divided into three major domains:
identification, characterization and manipulation. In general, assemblies of proteins have been analyzed
using two complementary approaches: the biochemical and the genetic. In the well-known analogy to
understanding how car runs, biochemists disassemble the engine, transmission and body, characterize all
the pieces and attempt to rebuild a working vehicle. Geneticists, by contrast, break single components,
turn the key and try to determine what effect the single missing part has on the car’s operation. This
implies that genetic methods often require a specific phenotype before they can be carried out.
Traditionally, the tools available to analyze protein-protein interactions in multicellular organisms have
been restricted to biochemical approaches. However, despite obvious advantages, biochemical
approaches can be time-consuming. Biochemical methods that detect proteins that bind to another
proteins generally result in the appearance of a band on a polyacrylamide gel. These methods are
sometimes referred to as physical methods and include protein affinity chromatography, affinity blotting,
immunoprecipitation and cross-linking (3).
Protein probing uses a labeled protein as a probe to screen an expression library in order to identify
genes encoding interacting proteins. Since all combinations of protein-protein interactions are assayed,
including those that might never occur in vivo, the possibility of identifying artifactual partners exists
and is a typical disadvantage of most exhaustive screening procedures. A second drawback derives from
the use of a bacterial host, where not all posttranslational modifications needed for the interaction might
occur. A third disadvantage is that screening rather than selection is used as the means of detection,
which inherently limits the number of plaques that can be assayed. The “Phage Display” method is
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noteworthy in this matter. Here the methodology is based on the fact that an Escherichia coli
filamentous phage can express a fusion protein on its surface.
A major advantage of the described method is the affinity purification step through “panning” cycles,
that enables one to enrich every cycle 1000-fold for specific phages that contain an interacting protein.
Disadvantages of phage display include the size limitation of protein sequence for polyvalent display and
the requirement that proteins be secreted form E. coli. Moreover, all phage-encoded proteins are fusion
proteins, which may limit the activity or accessibility for the binding of some proteins (3).
THE TWO-HYBRID SYSTEM
What is it?
Apart from the above-mentioned methods, a new technology has been developed during the past
decade. This technique, entitled “two-hybrid” or “interaction trap”, enables not only the identification of
interacting partners but also the characterization of known interaction couples and even embodies the
technological means to manipulate protein-protein interactions.
The modular properties of GAL4 and other transcription factors in general fostered this strategy. Indeed
many eukaryotic transcription activators have at least two distinct functional domains, one that directs
binding to a promoter DNA sequence and one that activates transcription (4,5). This fact was illustrated
by exchanging DNA binding domains and activation domains from one transcription factor to the next
while retaining its function. It was shown that the activation domain of yeast GAL4 could be fused to
the DNA-binding domain of E. coli LexA to create a functional transcription activator in yeast (6).
The “two-hybrid” technique exploits the fact that the DNA-binding domain of GAL4 is incapable of
activating transcription unless physically, but not necessary covalently associated with an activating
domain
Ma and Ptashne (7) demonstrated this principle for the first time. They showed that the GAL80 protein,
normally a negative regulatory protein that interacts with GAL4, could be converted into a
transcriptional activator by fusing it to an activation domain (AD). The activation by this fusion protein,
GAL80-AD, was dependent on the presence of a GAL4 derivative bearing the GAL80 binding domain
(C-terminal 30 amino acids) but lacking its own activation domain (7).
The actual use of those different functional modules of a transcription factor to study protein-protein
interactions was first proposed by Fields and Song (8). They demonstrated the “proof-of-concept” by
using SNF1 fused to the DNA-binding domain (DB) and SNF4 to an activation domain (AD). Only after
expression of these two chimeras, and subsequent interaction of SNF1 and SNF4, did they reconstitute a
functional transcription factor that is able to induce reporter gene expression. These initial experiments
confirmed that a transcriptional read-out could be used as a tool to study interactions between proteins
not involved in the transcription process.
Van Criekinge, W and Beyaert, R. 4
Biological Procedures Online • Vol. 2 No. 1 • October 4, 1999 • www.biologicalprocedures.com
In general, in any two-hybrid experiment a protein of interest is fused to a DNA-binding domain and
transfected in a yeast host cell bearing a reporter gene controlling this DNA-binding domain. When this
fusion protein cannot activate transcription on its
own, it can be used as “bait” or as a “target” to
screen a library of cDNA clones that are fused to
an activation domain. The cDNA clones within the
library that encode proteins capable of forming
protein-protein interactions with the bait are
identified by virtue of their ability to cause
activation of the reporter gene. So the yeast two-
hybrid system is devised to identify genes encoding
proteins that are physically associated with a given
protein in vivo. Since the emergence of the two-
hybrid approach in 1989, a number of
improvements have been incorporated that have
increased its applicability (
New developments).
Why not use the two-hybrid system?
It should be noted, however, that the two-hybrid
system does not provide a solution for all protein-
protein problems. For different experimental
reasons some proteins are not suited for this
approach. The sceptics about the use of the two-
hybrid system are furnished with a summary of the
extensive list of disadvantages and drawbacks in
the next paragraphs.
Since the read-out of the two-hybrid system makes use of a transcription event, one of the most crucial
initial experiments is to check whether your favorite protein (YFP) is able to initiate transcription. If this
is the case, it might seriously handicap the successful use of this protein in any two-hybrid approach (see
Auto-activation).
An obvious critique concerns the extensive use of chimeras. The use of artificially made fusion proteins
always embodies a potential risk. The fusion might change the actual conformation of the bait and/or
prey and consequently alter functionalities. This misconformation might result in a limited activity or in
the inaccessibility of binding sites. However, the use of tagged proteins in general has been very
successful in many biotechnological approaches. This success might rely on the fact that protein domains
can fold rather independently, enabling the co-existence of different, even artificially introduced,
modules in the same protein.
The best control to assay the correct conformation of your favorite protein is to clone a known positive
interactor in the appropriate vector and “two-hybrid-assay” this interaction. This will only work if both
Fig. 1: Principle of the Two-hybrid system. (A), (B) Two
chimeras, one containing the DNA-binding domain (DB:
blue circle) and one that contains an activation domain
(AD: half blue circle), are co-transfected into an appropriate
host strain. (C) If the fusion partners (yellow and red)
interact, the DB and AD are brought into proximity and can
activate transcription of reporter genes (here LacZ).
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proteins are folded correctly. This kind of experiment is only conclusive for the domains involved in the
“positive” interaction, which might differ from the ones involved in the new interactions that might be of
interest. In summary, this category of drawbacks can be labeled “(mys)steric”, related to folding and the
three dimensional structure of the protein assayed. In this respect it is noteworthy that the reciprocal
transfer of proteins, i.e. switching proteins from DNA-binding fusions to activating domain fusions, is
not trivial, supporting the fact that (mys)steric constraints on folding are involved. This switching or
“swapping” might provide an empirical way to escape the problem.
One of the most ambiguous disadvantages is that the two-hybrid system makes use of yeast, S.
cerevisiae, as a host. This implicates, as mentioned above, that YFP must be able to fold correctly and
exist as a stable protein inside the yeast cells. The use of yeast can also be seen as an advantage, since
yeast is closer to higher eukaryotics than in vitro experiments or those systems based on bacterial hosts.
A major disadvantage of assaying protein-protein interaction in any heterologous system is that some
interactions depend upon posttranslational modifications that do not, or inappropriately, occur in yeast.
Such modifications are frequent and include the formation of disulfide bridges, glycosylation and most
commonly phosphorylation. Some new two-hybrid systems, however, try to circumvent this
inconvenience by co-expressing the enzyme responsible for the posttranslational modification.
Since the two-hybrid system needs the fusion proteins to be targeted to the yeast nucleus, it might be a
disadvantage for extracellular proteins or proteins that contain strong(er) targeting signals.
When screening libraries, a good representation is crucial. In classical two-hybrid library preparations
only one out of six fused cDNAs is in the correct frame, pushing the total number of independent clones
to be screened to over a million, at the border of practical feasibility. Making directional libraries of a
relevant tissue or cell type might be a solution. Another solution might be to go for less complex
organisms like C. elegans.
Screening of libraries selects for optimized interactions. Many isolates may not represent full-length
cDNA. Indeed, it has been shown that subdomains may interact better than full-length clones, probably
reflecting domain function during folding of the protein. The best way to encompass this problem is
probably to clone only full-length cDNAs in the correct open reading frame. Although extremely labor
intensive, this approach was taken to establish the complete yeast protein linkage map (see Whole
genome approaches using the two-hybrid system).
Since only reporter gene activity is measured, it is impossible to exclude the possibility that a third
protein Z is bridging the two interacting partners. Although this possibility is rather unlikely and might
even be considered as “specific,” it holds for many of the conventional biochemical techniques.
Some proteins might become toxic upon expression in yeast. A number of proteins, such as cyclins or
homeobox gene products are indeed toxic when expressed and targeted into the yeast nucleus. Such
genes might be counterselected during growth and result in problems. The use of an inducible promoter
might circumvent the problem. Other proteins might proteolyse essential yeast proteins or proteins
essential for the system like the DNA binding domain or the activation domain.
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Since all combinations of protein-protein interactions are assayed, the possibility of identifying
artifactual partners exists and is a typical disadvantage of all exhaustive screening procedures. Due to
the so-called time/space constraints it is potentially possible that both proteins, although able to interact,
are never in close proximity to each other within the cell. The two proteins could be expressed in
different cell types, or even when found in the same cell they could be localized in distinct subcellular
compartments. Moreover, interacting proteins can be expressed at different points during embryogenesis
or during homeostasis (e.g. at different time points in the cell cycle). So once two interacting partners
are identified, the biological relevance of this interaction remains to be determined.
Why use the two-hybrid system?
Apart from the above-mentioned drawbacks, the two-hybrid system has some clear advantages over
classical biochemical and genetic approaches. First of all it embodies an in vivo technique using the yeast
host cell as a live test tube. This yeast system brings the higher eukaryotic reality closer than most in
vitro approaches or techniques based on bacterial expression. Appealing features of this system are the
minimal requirements to initiate a screening. Only the cDNA, full-length or even partial of the gene of
interest is needed, in contrast to sometimes-high quantities of purified proteins or good quality
antibodies needed in classical biochemical approaches.
Weak and transient interactions, often the most interesting in signaling cascades, are more readily
detected in two-hybrid since the genetic reporter gene strategy results in a significant amplification. It is
useful to keep in mind that there is a trade-off between the identification of weak interactions and the
number of false positives encountered when performing a screening procedure. Apart from the ability to
screen libraries, the two-hybrid system also allows for the analysis of known interactions. This can be
achieved by pinpointing crucial residues for interaction or by a functional characterization of the entire
subdomain. By doing semi-quantitative experiments one can even interpret affinities from two-hybrid
experiments. It was demonstrated that the strength of interaction as predicted by the two-hybrid
approach generally correlates with that determined in vitro, permitting discrimination of high-,
intermediate- and low-affinity interactions (34). In addition, binding affinities of peptides to
retinoblastoma (Rb), as determined by surface plasmon resonance, correlated with results from the two-
hybrid assay.
The two-hybrid system was predicted to be limited to the analysis of cytoplasmic proteins. Indeed
extracellular proteins or protein domains are often N-glycosylated and contain disulfide bonds, both of
which are not expected to occur in the yeast nucleus (9). However, several successes were reported
with transmembrane receptors. Appropriate extracellular receptor-ligand interactions were demonstrated
for the growth hormone,prolactin and growth hormone releasing receptors (10,11). Thus, receptors with
whole extracellular critical ligand binding determinants can sometimes be evaluated by the two-hybrid
system. But, it may be inappropriate for receptors with determinants in transmembrane domains that
form intramembraneous ligand binding pockets (11).
One of the most appealing features of the yeast two-hybrid system is that the identification of an
interacting protein implies that at the same time the corresponding gene is cloned. Two-hybrid screens
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are sometimes referred
to as functional
screens, since
interacting proteins
might give a functional
hint if at least one of
the partners has a
known functional
commitment in a well
understood signaling
pathway. Trying to
attribute function to an
unknown target is
often more difficult.
Here, the identified
partners need to be
known or the problem
will propagate.
Although the outcome
of a screening often
results in many new
hypotheses, they still
need to be validated by
other techniques. As a
conclusion, there is
enough reason to
remain sceptic about
two-hybrid screenings
but the most
convincing argument in
favor of the two-hybrid
is the number and
speed in which many
signaling cascades have
been resolved in
molecular detail.
Fig. 2: General flowchart of a hypothetic two-hybrid screen. Pointed lines should be
followed in case of negative results.
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MATERIALS AND METHODS
Introduction
Actual screening involves many choices, since several comparable two-hybrid systems are available.
Many of the most encountered problems and potential pitfalls are reviewed in this section. In most cases
a typical two-hybrid experience goes through a sequence as outlined in Fig. 2.
Construction of the “target” or “bait”
When performing a two-hybrid screen, the first decision to be made is the choice of the most
appropriate vector system. A large number of different DNA-binding domain (DB) and transcription
activation domain (AD) containing vectors have been used successfully. The most extensively used
vectors are GAL4 based, probably because they were the first commercially available. Alternative
systems make use of the DB of the bacterial LexA protein and the AD of VP16 or the so-called B42AD.
Both systems, GAL4 and LexA, have advantages and drawbacks which make the choice more difficult.
In the following paragraphs the major differences between the two systems will be pointed out together
with the major pitfalls in a typical screening procedure. Since the LexA and the GAL4-based two-hybrid
systems have different properties, it is not unreasonable to imagine that some interactions might be
detected differently in both systems. Trying both will increase the chance of success.
The promoter regulates the expression level of the target protein
The 1500-bp full length ADH1 promoter, that normally drives the expression of the metabolic enzyme
alcohol dehydrogenase 1, leads to high-level expression of sequences under its control. This promoter is
used in the pAS2(-1) and pLexA plasmids that are used to clone the target-fusion. It is also present in
pGAD-GH that can be used to clone the cDNA library. Expression from this promoter is maximal
during logarithmic growth of the yeast cells and becomes repressed in late log phase by ethanol
accumulation in the medium. This explains why Western blot analysis of the expressed fusion protein
gives the best results when logarithmic growing yeast is used. Although the ADH1 is generally
considered to be a strong constitutive promoter, expression is actually repressed as much as 10-fold on
non-fermentable carbon sources (12). In contrast to this full-length promoter, several cloning vectors,
including pGBT9 (DB) and pGAD424 (AD) contain a truncated 410-bp ADH1 promoter. Expression
from this promoter leads to low or very low levels of fusion protein expression that are hardly detectable
on a Western blot (13-15). The choice of expression plasmid might be influenced by the nature of the
target. If the target is expected to interfere with the endogeneous yeast metabolism, a lower expression
might be beneficial. However if the expression of the fusion-protein needs to be assayed, the higher
expression level is more convenient. Legrain et al. (15) used known interaction partners to study the
influence of expression levels of the fusion proteins on their detection sensitivity in two-hybrid assays.
Combinations of weak expressing plasmids revealed that detection of these interactions was roughly 50-
100 times less sensitive. Therefore, an interaction assayed by use of these plasmids may sometimes
escape detection. Important, however, is to notice that this observation was strongly dependent upon
the protein-couples used. Some protein combinations were unaffected in sensitivity whereas others
dropped only 10-fold. Another important but less documented parameter is the relative position of the
various “cassettes” in the different vectors. A simple correlation between sensitivity and length of the
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promoter fragment used is excluded since the use of other plasmids containing the same proteins under
the same truncated promoter did not result in a loss of sensitivity (15).
Total expression level does not only depend on the promoter strength and the carbon source used, but
also on the copy number of the plasmid. In most commonly used two-hybrid plasmids, the origin of
replication is the so-called 2m m origin. The 2- m m circle plasmids are maintained stable and at high copy
numbers (50-100 copies per cell) in yeast, and function solely for their own replication (16). It was
shown that 2- m m DNA replication is similar to chromosomal DNA replication. 2- m m DNA is the only
known example of a multiple-copy extrachromosomal DNA in which every molecule replicates in each
cell cycle (17). It should be noted that in the context of a reverse hybrid system (see Reverse Hybrid
System), the expression levels of the hybrid proteins should be maintained as low as possible, since
every “background” interaction, which might occur more often at high protein expression levels, will kill
the yeast. Therefore, the vectors used in these reverse hybrid systems make use of low-copy, so-called
centromeric, expression plasmids. The difference in expression levels between high- and low-copy
plasmids can be as much as twenty- or thirty fold. Also when using toxic proteins, the use of these
centromeric vectors in forward screens can be taken into consideration.
Features of target/bait vectors
The pAS vectors also encode a hemaglutinin (HA), YPYDVPDYA, epitope tag in frame with the
GAL4DB (18). This allows the protein to be visualized with commercially available anti-HA antibodies.
There has been some controversy about the introduction of the HA tag since this results in a weak auto-
activation when the empty vector is transformed and reporter gene activity is measured. However, when
a protein is fused in frame, in general, the fusion protein looses the auto-activation properties. In
principle, this could be used as an “in-frame control” but it has never been advertised in this way. It
might however explain why in the new version of the pAS2, named pAS2-1, the HA tag is removed.
The same HA is now introduced in pACT2, which is the successor of pGAD424. Other characteristics
that might influence the choice of a vector are from a more practical nature. In all vector systems care
must be taken to maintain the proper reading frame when creating the two-hybrid proteins.
Compatibility of the multiple cloning site (MCS) in the DB and AD containing vector can be beneficial.
Cloning in both vectors permits both verification of the correct length on Western blot and enables the
establishment of a panel to score new targets in simple co-transformation or mating experiments.
Another “add-on” found in some of the commercially available vectors is the CYH2 gene. CYH2
encodes the L29 protein of the yeast ribosome. Cycloheximide (Chx), a drug which blocks polypeptide
elongation during translation, prevents the growth of cells that contain the wild-type CYH2 gene. Chx
resistance results from a single amino acid change in the CYH2 protein (19). When a wild type CYH2
containing plasmid is present in a mutant yeast strain resistant to Chx, it confers Chx sensitivity. Adding
Chx to the medium results in a selection for yeast that has lost the CYH2 containing plasmid. This
technique might be useful to select for only the library insert containing plasmid after screening (see
Separating the two-hybrids). A potential danger is that due to leakage on the promoter of this CYH2
gene the yeast growth is retarded.
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Most two-hybrid strains have a lesion in either URA3, LEU2, HIS3, TRP1 and/or ADE2 which allows
selection for yeast cells that were transformed with plasmids that carry the corresponding gene by
growth in the absence of the appropriate amino acids. The most widely used markers in yeast are genes
encoding amino acid biosynthetic enzymes. However, in a recently introduced target vector
(pHybLex/Zeo) zeocin is used as selection marker. Parent et al. (17) have compiled an extensive list of
yeast cloning vectors. In addition, a list of the most commonly used plasmids in two-hybrid and their
distinguishable features is listed in Table 1.
Table 1: Overview of the most commonly used two-hybrid vectors. The last column describes the
origin of the promoter and the accession number in EMBL (AC)
Name Selection-
marker
Functional domain promoter, AC
GAL4-based
pMA424 HIS3 GAL4DB Original vector, 12 kb
pGBT9 TRP1 GAL4DB ADH1(truncated)
AC: U07646
pAS1 TRP1 GAL4DB+HA ADH1(full length),
CYH2
pAS2 TRP1 GAL4DB+HA ADH1(full length)
CYH2
AC: U30496
pAS2-1 TRP1 GAL4DB ADH1(full length)
CYH2
AC:U30497
pGAD2F LEU2 GAL4AD Original vector, 13 kb
pGAD424 LEU2 GAL4AD ADH1(truncated)
AC:U07647
pGAD10 LEU2 GAL4AD ADH1(truncated)
AC:U13188
pGAD-GL LEU2 GAL4AD ADH1(truncated)
pGAD-GH LEU2 GAL4AD ADH1(full length)
pGAD1318 LEU2 GAL4AD ADH1(full length)
pSE1107 LEU2 GAL4AD
pSD-10 URA3 VP16AD
pACT1 LEU2 GAL4AD
pACT2 LEU2 GAL4AD+HA ADH1(truncated),
medium expression
AC:U29899
LexA-based
pBTM116 TRP1 LexA ADH1(truncated)
pLexA HIS3 LexA ADH1(full length)
= pEG202
pB42AD TRP1 B42+ SV40 NLS + HA GAL1 (full length),
inducible promoter
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= pJG4-5
pHybLex/Zeo Zeocin LexA ADH1(truncated)
pYESTrp TRP1 V5 epitope + SV40 NLS +
B42
GAL1 (full length),
inducible promoter
pGilda HIS3 LexA GAL1 (full length), inducible
promoter
centromeric vector
Sequencing and Western Blot analysis
Before proceeding with actual screening it is advisable to check the chimeric cDNA by sequencing and
to verify the actual expression of the fusion protein inside yeast. The latter can be achieved by “classical”
SDS-PAGE and subsequent Western blot analysis as outlined in Protocol 1. Both anti-GAL4DB and
anti-LexA antibodies are commercially available (Clontech #5399-1). This is preferably performed on
the yeast strain used for screening the library to be sure that the target is properly expressed (20).
Protocol 1 SDS-PAGE and Western blot analysis to check for full-length expression of the target
fusion protein in the GAL4 system
After transformation of the plasmids encoding GAL4DB fusion proteins into Saccharomyces cerevisiae strain
HF7c and incubation on plates lacking the appropriate amino acids (e.g.Trp), single colonies are inoculated
into 15 ml synthetic medium lacking the same amino acid(s). At an optical density (A600) around 0.7, the
culture is centrifuged at 2500 rpm for 5 min, the pellet is washed in distilled water and boiled for 3 min in 200
µl of 2 x Laemmli loading buffer. 50 µl of this sample is separated by 10% SDS-polyacrylamide gel
electrophoresis and blotted onto a nitrocellulose membrane (Schleicher & Schuell, Dassel, F.R.G.). Detection
of the expressed fusion proteins can be performed with polyclonal anti-yeast GAL4DB antibody and
peroxidase-conjugated anti-rabbit antibody using ECL (Amersham Life Science, Amersham, U.K.).
Auto-activation
Since the two-hybrid system is based on reconstitution of a functional transcription factor, checking the
auto-activation capacity of the target is crucial for the overall feasibility. Initiation of transcription, due
to some latent activating activity is present in approximately 5% of all proteins and even more in
randomly generated fragments (like in libraries). The use of a library fused to the DNA binding domain
would result in a large amount of false positives illustrating that auto-activation can cause problems.
Since DNA-binding to the upstream activating sequence (UASG) is more stringent, it provides a rational
for making the libraries in the vector containing the AD.
A single transformation and reporter gene assay tells you whether your favorite protein (YFP) is able to
induce reporter gene activity. What if YFP is auto activating? If it is only weak, e.g. only a minor
background on the HIS3 and not on LacZ, one could try to increase the amount of AT in the plates (see
Pilot transformation in the GAL4 system). In the LexA system using less sensible reporter hosts or LacZ
expressing plasmids containing variable DNA binding regions can genetically control the sensitivity. This
ability to tune genetically the sensitivity of the reporter might be one of greatest advantages of the LexA
system (see Table 4). If this tuning does not help, more radical approaches need to be applied. It is often
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possible to delete a small region of a protein that activates transcription. Removal of this activation
function while retaining other properties of the protein might enable the use of the target to screen
libraries. Alternatively, instead of using a C-terminal fusion to the DB, an N-terminal fusion can be tried.
Indeed normal two-hybrid methods detect interactions between two proteins fused at the C-termini of
the DB and AD, respectively. This implicates that the N-terminus of none of these proteins is available
for interaction. It was demonstrated, using constructs with reverted polarity, that such constructs give a
specific interaction signal that is dramatically increased. Such constructs might lead to the identification
of partners missed during classical two-hybrid screens and might at least in some cases provide a
solution to the auto-activation problem (21).
In theory, another solution could be considered. If auto-activation is strong like in the case of
transcription factors, it could be possible to apply a reverse approach. By using a toxic reporter gene
and an auto-activating target under an inducible promoter, all yeast cells that are not repressed by an
interaction, will die upon induction of the promoter. All yeast cells surviving such a screening procedure
should contain a plasmid encoding an interaction partner of the auto-activating bait.
Nuclear localization: the repression assay
Another requirement, apart from correct folding of the fusion protein and impossibility to initiate
autonomously transcription, is the ability of the fusion to be localized to the yeast nucleus. Indeed all
transcription events are dedicated nuclear processes. Specific binding of GAL4 to the (UAS)G is
conferred by a zinc-cluster motif located within the N-terminal 64 residues (5,22,23). GAL4 binds as a
dimer to DNA, which is mediated at least in part by an a -helical region within residues 65-94 which
form a coiled-coil interaction (23-24). GAL4DB also has its own nuclear localization signal (NLS)
within its N-terminal 74 residues (25-27). A positive control can be used to check the nuclear
localization in the GAL4 system. Unless, in the case of auto-activation, where apart from the problems
described above, the nuclear localization problem is trivial.
Since LexA is a bacterial protein it contains no NLS. Therefore, the NLS of SV40 large T is fused in
frame ensuring nuclear localization. The nuclear localization of LexA fusions can be assayed by a so-
called “Repression” or “Blocking assay”. The repression assay is based on the observation that LexA
and non-activating LexA fusions can repress transcription of a yeast reporter gene that has LexA
operators positioned between the TATA and upstream activating sequence (UAS) (28). LacZ
expression is induced by galactose and is detectable in the presence of glucose. A transcriptional inert
LexA fusion that binds to the operator located between the UASG and the TATA box is able to repress
or block the LacZ expression, a clear indication that the LexA fusion is properly located to the yeast
nucleus. The reporter plasmid pJK101 is used to perform this repression analysis. Since repression is
never complete, a positive and negative control is needed to calibrate the repression capability of the
protein assayed.
One could argue that nuclear localization of the target or prey as such is not strictly required. Indeed, if
interaction occurs in the cytoplasm, both interacting proteins, of which only one contains a NLS, might
be targeted to the nucleus. However, this might only be true for strong interactions that are not always
the most interesting.
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Positive control
The best way to avoid most problems concerning bait construction is to clone a known interactor in the
opposite vector and to assay the interaction in a two-hybrid system. If this results in specific reporter
gene activation, your fusion protein is correctly folded and properly targeted to the nucleus. However, if
this test fails, finding out why, might be cumbersome.
Library choice
It is always a good idea to start with a library prepared from a tissue in which the target protein is
known to be biologically relevant. To screen a mammalian cDNA library until saturation, more than 5-
10 x 106 yeast transformants need to be screened. Both oligo-dT and random primed libraries are used.
Important quality parameters are the number of independent clones before and after amplification, the
number of clones that contain an insert and the mean insert length. Having multiple cloning sites
available in the library plasmid is beneficial to subclone in later stages the insert for additional interaction
controls outside the two-hybrid system. The most commonly used plasmids for library construction are
listed in Table 1.
Important is also the relative strength of the activation domains, indicating their ability to initiate
transcription. Both VP16 and the AD of GAL4 are known to be strong activators making the system
more sensitive. This might be needed for the detection of weak interactions but results inevitable in
higher backgrounds. Therefore the use of B42AD, a random fragment that was isolated for its
intermediate transactivation capability, might be beneficial in setting up a screening.
For the library plasmid there is a major difference in promoter between the LexA and GAL4 system.
While in the most commonly used plasmids of the GAL4 system, fusion proteins are weakly and
constitutively expressed, they are cloned behind a stronger but inducible promoter in the LexA system.
In the latest version of the library plasmid used in the GAL4 system, pACT2, a truncated weakly
expressing version of ADH1 is used. However, since this promoter is adjacent to a section of pBR322
that acts as a transcriptional enhancer in yeast, a medium expression level is obtained.
Inducible expression has the advantage that there is less opportunity for AD fusions proteins to have a
toxic effect on the yeast host, which could also result in the elimination of this protein from the pool of
potentially interacting proteins. However, the experimental protocol is longer in the case of induction
since transformation efficiency drops dramatically if the transformations are directly selected on all
auxotrophic markers and on a carbon source that induces expression of the library fusion protein.
Therefore, one typically selects for all plasmids before induction. Although this procedure is longer, it
might be beneficial since only part of the original transformation mix needs to be induced, enabling
means to perform screening in shifts and having back-ups in case of contamination. It is possible to
combine vectors as long as they are compatible with each other with regards to the selectable markers
and the UAS before the reporters (see Table 2) (29).
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Table 2: Comparison of the LexA and GAL4 Yeast Two-Hybrid Systems
DB vector
selection
marker
AD vector
selection
marker
Chromosomal
reporter gene(s)
Plasmid reporter
gene
GAL4 Systems TRP1 LEU2 HIS3, LacZ (none)
LexA Systems HIS3 TRP1 LEU2 LacZ
Choose a yeast strain as a host
Reporter gene(s) and resulting sensitivity
The upstream activating regions and TATA regions are the basic building blocks of yeast promoters.
The initiation of gene transcription in yeast, as in other organisms, is achieved by several molecular
mechanisms working in concert. All yeast genes are preceded by a region containing a TATA box. Many
genes are also associated with cis-acting transcription elements and sequences to which transcription
factors and other trans-acting regulatory proteins bind and affect transcription levels. The term promoter
usually refers to both the TATA box and these associated cis-regulatory elements. Gene regulation in
yeast involves cis regulatory elements that are relatively closely associated with the TATA box. The
most common type of cis-acting transcription elements in yeast are upstream activating sequences
(UAS). UAS sequences are recognized by specific transcriptional activators that enhance transcription.
The enhancing function of yeast UASs is generally independent of the orientation but it is sensitive to
distance effects, if moved more than a few hundred base pairs from the TATA region. There may be
multiple copies of a UAS upstream of a yeast coding region. In yeast, the genes required for galactose
metabolism are controlled by two regulatory proteins, GAL4 and GAL80, as well as by the carbon
source in the medium (30). When galactose is present, the GAL4 protein binds to the GAL-responsive
elements within the UAS of at least 20 known galactose-responsive genes (including GAL1). In the
absence of galactose, GAL80 binds to GAL4 and this interaction blocks transcriptional activation.
Furthermore, in the presence of glucose, transcription of galactose genes is immediately repressed. The
17-mer consensus sequence, referred to as UASG, functions in an additive fashion. Indeed multiple sites
lead to higher transcription levels than a single site (31). This explains why the number of UASG located
before the reporter determines the sensitivity of the interactions that can be assayed.
To avoid interference by endogeneous GAL4 and GAL80, proteins the yeast host strains used in the
GAL4 based two-hybrid system must carry deletions of the GAL4 and GAL80 genes. Due to the
deletion of these two genes, the yeast cells grow more slowly as compared to yeast containing the wild
type version of these genes. The use of bacterial LexA circumvents this disadvantage.
Reporter genes can be integrated into the genome or reside on a plasmid. The inconvenience of having
another plasmid containing the reporter gene, and the need for an additional auxotrophic marker is
compensated by several advantages. Indeed, one of the major advantages of the LexA system, where the
LacZ reporter gene is present on a high copy-number plasmid, is that weak signals are more efficiently
amplified than in the GAL4 system, which makes it possible to assay b -Galactosidase activity directly on
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the selection plate by including X-GAL in the medium. This avoids tedious replica and/or filter lift
assays.
Reporter strains in LexA and GAL4
In the GAL4-based MATCHMAKER two-hybrid system, either the intact GAL1 UAS, which contains
four GAL4-binding sites, or an artificially constructed UAS consisting of three copies of the 17-mer
consensus binding sequence is used.
Table 3: Survey of the most commonly used yeast strains, used reporter genes and the constitution
(origin) of their promoter in the GAL4 based two-hybrid system.
Expression
Reporter
genes
UAS regulated by +
origin of UAS uninduced induced
H7Fc LacZ,
HIS3
GAL4, 3 x UASG 17-mer
GAL4, GAL1 (= 4 x UASG 17-mer )
-
-
low
high
YRG-2 LacZ,
HIS3
GAL4, 3 x UASG 17-mer
GAL4, GAL1 (= 4 x UASG 17-mer )
-
-
low
high
SFY526 LacZ GAL4, GAL1 (= 4 x UASG 17-mer ) -  high
Y187 LacZ GAL4, GAL1 (= 4 x UASG 17-mer ) -  high
Y190 LacZ,
HIS3
GAL4, GAL1 (= 4 x UASG 17-mer )
GAL4, GAL1 (= 4 x UASG 17-mer )
-
low
high
high
CG-1945 LacZ,
HIS3
GAL4, 3 x UASG 17-mer
GAL4, GAL1 (= 4 x UASG 17-mer )
-
very low
low
high
L40 HIS3,
LacZ
4 x LexA op
8 x LexA op
The relative sensitivity of both reporter genes used in the GAL4 based approach, respectively LacZ and
HIS3, depends entirely on the constitution of the promoter. In the GAL4 system the LacZ is more
stringent, meaning less likely to give false positives, than the HIS3 gene. This was elegantly
demonstrated in a recently described reverse three-hybrid approach. Here the expression of Raf from a
third promoter could titrate out the Ras-DB fusion, keeping it from interacting with Raf-AD fusion. This
reverse experiment resulted in the expected LacZ negative phenotype but not in a HIS3 negative
phenotype, reflecting the higher sensitivity of the histidine reporter gene as compared to the b -
galactosidase reporter gene in HF7c (32).
In LexA-based two-hybrid systems, the DB is provided by the entire prokaryotic LexA protein. LexA
normally functions as a repressor of SOS genes in E. coli by binding LexA operator sequences that are
an integral part of the promoter (33). When used in the yeast two-hybrid system, the LexA protein does
not act as a repressor because the LexA operators are integrated upstream of the minimal promoter and
coding region of the LEU2 reporter gene. Expression of the latter in EGY48 (Erica Golemis Yeast) is
Van Criekinge, W and Beyaert, R. 16
Biological Procedures Online • Vol. 2 No. 1 • October 4, 1999 • www.biologicalprocedures.com
under the control of six copies of the LexA operator (op) sequence and a minimal LEU2 promoter. In
the LacZ reporter plasmids, the LacZ reporter expression is under the control of 1-8 copies of the LexA
operator and the minimal GAL1 promoter (34).
As all of the GAL1 UAS sequences have been removed from the LacZ reporter plasmids. This
promoter is not regulated by glucose or galactose (35).
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Table 4: Tuning sensitivity in the LexA system by using different host strains and reporter plasmids
EGY reporter strains listed by decreasing sensitivity
EGY 48 colE1 LexA operators = 6 LexA binding sites + TATA + LEU2
EGY 194 2 colE1 LexA operators = 4 LexA binding sites + TATA+ LEU2
EGY 188 1 colE1 LexA operators = 2 LexA binding sites + TATA + LEU2
EGY 40 contains no LEU2 reporter gene
LacZ reporter plasmids listed by decreasing sensitivity
pSH18-34 4 colE1 operators, 8 LexA binding sites + TATA + GAL1-LacZ
pJK103 1 colE1 operators, 2 LexA binding sites + TATA + GAL1-LacZ
pRB1840 1 recA LexA operator + TATA + GAL1-LacZ
Finally there are many “hybrid two-hybrid systems” that combine GAL4 and LexA based systems. The
reporter strain L40 permits the use of the same reporter genes as in the GAL4 system but under control
of LexA operators. This permits the use of the plethora of libraries commercially available for the GAL4
system in a LexA related system.
Why use multiple reporter genes
The most significant improvement that accounts largely for the success of the two-hybrid system has
been the conversion from a color-based assay to a nutritional selection via inclusion of the HIS3 gene as
a transcription reporter in addition to LacZ. This allows much larger libraries to be efficiently screened
on far fewer plates. Apart from a higher plating density, the use of multiple reporter genes has many
additional advantages. The use of two reporter genes under the control of a similar promoter but at
distinct places of the genome can eliminate many false positives. Continuous histidine selection
throughout subsequent procedures eliminates irrelevant library plasmids that may have been
cotransformed with the actual plasmid of interest that initiated reporter gene activity. Moreover,
plasmids that are toxic to the yeast can undergo rearrangements or mutations that eliminate expression
of the activation domain hybrid. Since loss of the activation domain results in loss of reporter genes,
these yeast cells do not survive under auxotrophic selection. The b -galactosidase activity of
transformants under HIS3 selection is generally enhanced, probably because the transformants are forced
to produce the hybrid proteins in quantities that enable the HIS3 gene to be expressed at levels that
permit growth.
Pilot transformation in the GAL4 system
Since HIS3 has a leaky expression in many yeast strains, it is recommended to inhibit the basal
expression of this gene with 3-amino-triazole (AT), a known inhibitor of the HIS3 gene product.
Therefore, before starting a large-scale transformation procedure it could be very informative to perform
a pilot transformation that enables titration of the optimal amount of AT needed. Using too much AT
will result in a loss of weak interactions, whereas the use of no or too small amounts AT results in
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unworkable numbers of false positives.
The exact amount is largely dependent on
the yeast strain and upon the target used.
The reason why Y190 requires more AT
to bring down the background expression
of HIS3 as compared to HF7c is related
to the origin of the TATA sequence. In
most cases the TATA box of GAL1 is
used in front of HIS3 (and the one of
CYC1 in front of LacZ) except in Y190
where the TATA box of HIS3 is used.
Typically a couple of strong, weak and
intermediate interacting proteins are
transformed together with the target and
a dilution of library cDNA. These are
plated on a logarithmic gradient of AT
(0,5,10,25 and 50 mM of AT). This
generally results in growth as shown in
Figure 3. Here the optimal AT would be,
enough to suppress background and not
too much to be able to detect the weak interactions.
Library Transformation
Transformation efficiency
Transformation efficiency is often the bottle neck when performing two-hybrid experiments. The basic
idea is  to saturate the screening to obtain as many transformants as possible, and to avoid
transformation of a single yeast cell with multiple library plasmids, which can seriously complicate
subsequent analysis, the lowest amount of DNA needs to be used. A maximum number of transformants
with a minimal amount of DNA requires a high transformation efficiency.
There are several commonly used methods to introduce plasmid DNA into yeast. These include the
spheroblast method, electroporation and the lithium acetate method (LiAc) (36-38). Although the
spheroblast method results in high transformation efficiencies, it is too much time-consuming for large-
scale experiments like library screenings. In general, electroporation offers the highest transformation
efficiency, and is especially useful when small quantities of DNA are transformed. Unlike the lithium
acetate (LiAc) based method, electroporation saturates at low DNA levels, restricting its use in a two-
hybrid approach. Taken together, all two-hybrid protocols make use of the LiAc method, which is a
quick method to introduce foreign DNA into the yeast in a large scale experiment.
In the LiAc transformation method, yeast competent cells are prepared and resuspended in a LiAc
solution together with the plasmid DNA to be transformed and an excess of carrier DNA. Polyethylene
Figure 3: Determination of optimal AT concentration in a pilot
transformation using strong, weak and intermediate interactors as
positive and negative controls. Cells are plated out on a AT gradient.
The optimal AT concentration (dotted double arrow) is this which
elimates false positives (e.g. formed in case of bait + empty library
plasmid but which still allows to detect weak interactions).
Van Criekinge, W and Beyaert, R. 19
Biological Procedures Online • Vol. 2 No. 1 • October 4, 1999 • www.biologicalprocedures.com
glycol (PEG) with the appropriate amount of LiAc is then added to the mixture of DNA and yeast, and
the mixture is incubated at 30°C. Before or after the incubation, DMSO is added and the cells are heat
shocked, which allows the DNA to enter the cells. The cells are then plated on the appropriate medium
to select for transformants containing the introduced plasmids (Protocol 2).
Many versions of this LiAc based protocol are available, probably illustrating that many of the different
steps can be subject to change and are not strictly required for the final outcome. Like every
transformation procedure, the exact mechanism of DNA uptake is not known, which makes all protocols
highly empirical.
Of crucial importance in every strategy are the yeast cells used. Since growth on a master plate does not
give any selection criteria for “transformability”, there is always a risk of selecting for yeast cells that are
more difficult to make competent for transformation. Best practice is to keep a stock of (competent)
yeast cells known to be good for transformation. Even by using yeast cells known to have worked in
previous experiments, it is advisable to perform several transformations in parallel. A second parameter
found to be important is the growth phase. With respect to this, logarithmic growing cells were shown
to be the best. Maximal transformation efficiency in each of the procedures depends on finding the
optimal cell density. The cell density can be “controlled” by making appropriate dilutions and
determining the optical density at 600 nm at different times. However, the best method is to look
through the microscope and count the percentage budding yeast cells and calibrate this percentage to the
number of transformants obtained. Important to notice is that the total volume of cultures is equally
important. Too many yeast cells in a tranformation mix will significantly drop the efficiency and will give
difficulties to spread on the plates. Too dense plating might result in higher background since more
slowly growing yeast cells can grow on the corpses of others. Also crucial in two-hybrid experiments is
the total amount of DNA used. The use of too much DNA in the transformation-mix might be fatal, not
only because most protocols will saturate at a given amount of DNA, but it will increase the chance of
multiple library plasmids to enter the same host cell. This will make subsequent analysis very hard. The
quality of plasmid DNA is said to be less crucial since impurities resulting from the preparation method
might function as carrier and consequently increase transformation efficiency.
Another critical parameter is the quality of carrier DNA, which must be of high molecular weight and
completely denatured. Denaturation can be achieved by repeating the cycle of boiling and chilling
immediately before use. Achieving the proper DNA size distribution upon sonication is probably the
most difficult. Instead of running agarose gels to check the size distributions, a more direct way is to use
several batches in a transformation experiment and retain the one that gives the highest transformation
efficiency regardless of its size distribution. Competence of DNA uptake at the level of the cell wall is
induced by treatment with both lithium ions and PEG (3350-4000). Some people claim that the quality
of a PEG stock buffer decreases over time and might result in low transformation efficiency.
To ensure that all plasmids are present and the target is correctly expressed, a small aliquot of the
competent yeast cells can be used to transform a positive control. One of best resources on
transformation of yeast can be found on the webpage of the Gietz Lab (39).
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Protocol 2 Overview of a typical library screening protocol
1. Start with a master plate of yeast transformed with the target DNA binding domain-fusion
protein (don’t keep master plates longer than 2 weeks and store them at 4°C)
2. Inoculate four 20-50 ml cultures of a single large colony, in SD medium that selects for the
target protein (e.g. -Trp)
3. Grow for 36-48 hours (until culture becomes “milky”)
4. Transfer each of these cultures to a 200 ml culture
5. Grow overnight
6. In the morning, transfer entire 200 ml into 400 ml of YPD (OD should be around 0.2 in a
total volume of 600 ml)
7. Grow to an OD600 of about 0.7-0.75 (about 4 hours)
8. Transfer cells into 250 ml bottles (in shifts). Spin at 2200 rpm (1000 X g) for 5 min. Keep the
four pools separated throughout the protocol
9. Remove supernatant and resuspend in water. Spin 2200 rpm for 5 min.
10. Remove supernatant and resuspend cells, 4 batches, with about 10 ml of 1 X TE/LiAc (made
fresh) per bottle.
11. Bring to a 50 ml tube. Spin 2200 rpm for 5 min
12. Remove supernatant. Bring final volume up to 2 ml with 1 X TE/LiAc.
13. Do transformations in 4 x 10 eppendorfs containing:
200 m l yeast cells
8 m g library DNA
30 m l salmon sperm DNA (10 mg/ml)
7 m l 10 X LiAc/TE
30 m l DMSO
1.2 ml PEG/LiAc (freshly made !)
14. Vortex and flick to assure DNA is well distributed
15. Incubate at 30°C for 30 min while gently shaking in thermomixer, flick every 10’
16. Incubate at 42°C in thermomixer
17. Chill cells on ice (1’) and spin at 2600 rpm for 1’
18. Resuspend in 300 m l 1 X TE
19. From each eppendorf, plate an equal amount (133 m l per plate) onto 3 plates lacking the
appropriate amino acids: total of 4 x 30 large plates
20. Plate dilutions (1/1000, 1/10000 & 1/100000) on -Trp & -Leu plates to assay transformation
efficiency, for each of the 4 competent yeast batches
21. Put plates at 30° C for 1-2 weeks
Simultaneous versus sequential transformations
The LiAc methods typically result in transformation efficiencies of 105 transformants per m g of DNA
when using a single type of plasmid. When the yeast is simultaneously cotransformed with two plasmids
having different selection markers, the efficiency is usually an order of magnitude lower due to the lower
probability that a particular yeast will take up both plasmids. Yeast, unlike bacteria, can support the
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propagation of more than one plasmid having the same replication origin. Although simultaneous
transformation is less efficient, it might be beneficial to use this strategy. Apart from being easier,
simultaneous transformation avoids a growth phase after the first transformation that might result in
counterselection. Indeed, if the expressed protein is toxic or interferes with normal yeast metabolism,
arising clones might have spontaneous deletions in the first plasmid which confer a growth advantage.
Nevertheless, in order to saturate screening, it is advisable to perform sequential transformations which
mostly results in a few million transformants.
In the inducible LexA system it is advisable to select first for transformants, (sequentially induced most
of the time), and in a second step to induce the expression of the cDNA library insert. This two-step
approach results in a uniform increase in the number of cells carrying each library plasmid. Before
harvesting, each cell transformed with the library is allowed to form a colony of approximately the same
size. One advantage of this approach is that the number of transformed yeast cells is amplified before the
synthesis of cDNA encoded proteins. This ensures that yeast cells containing toxic or mildly toxic cDNA
encoded proteins will not be depleted from the population.
Picking positive colonies
In the GAL4 system, transformants are plated out on plates that are selective for the two plasmids and
the additional auxotrophic reporter gene HIS3. Colonies able to grow on this medium are in principle
inducing HIS3 as a result of protein-protein interactions that reconstitute a functional GAL4. The size of
the colony might reflect the strength of the interaction. However, there is no reason to assume that weak
interactions have less biological significance than strong ones. So, when picking colonies, care must be
taken to evaluate the size of each colony to the background and not preferentially picking the largest
colonies. The same holds for weak and strong LacZ+ after assaying for b -galactosidase activity.
In general after 5-6 days the first colonies can be picked and transferred in e.g. 96 well plates. After 2-3
hours they can be replica plated onto plates lacking the appropriate amino acids and the titrated amount
of AT (master plate), and at the same time onto plates covered with a filter membrane. Since colonies
grow through the filter, it facilitates the lifting procedure and subsequent lysis in liquid nitrogen. It is a
good idea to include here a positive (preferably a strong, intermediate and weak interaction) and a
negative control. If not too many clones need be assayed, the 96 well procedure can be replaced by
replica striking directly on a master and filter containing plate. In order to pick also slower growing
colonies, this procedure is repeated after 12-15 days, largely depending upon the number of colonies
obtained.
When performing a b -galactosidase test, care must be taken to the growth phase of the yeast. Again,
fresh logarithmic growing yeast cells will give the best results. Strong interactions should be visible after
2 hours, intermediate ones might take 6 hours while weak interactions might need to be incubated
overnight. The incorporation of both the positive and negative controls on the same filter is the only
relevant reference point. It should be noted that not all HIS3+ are LacZ+. Due to the earlier described
different sensitivities of both the HIS3 an LacZ phenotypes it is usually found that HIS3+ and LacZ+ cells
contain the most biologically relevant interaction, however, it cannot be excluded that HIS3+ and LacZ-
cells are of potential interest.
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Rescue of library plasmid
Preparation of DNA from yeast
After the difficulties to get the DNA inside the yeast, the problem of getting it out is easier to solve..
Many protocols yield  little, but nevertheloss a sufficient amount of DNA that can be transformed to
bacteria where it can be amplified for further analysis. One of the pitfalls is that apparently most DNA
precipitates prepared from yeast contain debris of the yeast outer membranes that appears to be toxic for
most competent bacteria. By diluting this debris below toxic levels, the equivalent drop in DNA
concentration requires a very efficient bacterial transformation.
Separating the two-hybrids
The positive yeast host cells contains two different two-hybrid plasmids, one encoding the bait and
another containing the library insert. There are several procedures to enrich for the plasmid containing
the library insert. One option makes use of the CYH2 gene on the target plasmid, that confers
cycloheximide sensitivity to the yeast host. By adding cycloheximide to the medium, it is possible to
select for cells that have lost this plasmid. Another protocol makes use of bacteria (HB101) that are
unable to grow on media lacking leucine. Only by transformation of a plasmid containing the LEU2
gene, which happens to be the one containing the library insert, these bacteria can be rescued. It should
be noted that this procedure is not trivial since HB101 grows very slowly (3 days) and DNA prepared
from this strain can be hard to sequence. Alternatively, yeast DNA can be prepared and directly, without
any selection procedure, transformed into bacteria (MC1061) (Protocol 3). In theory 50% of the
transformed bacteria contain the library plasmid. A simple and highly efficient procedure for rescuing
autonomous plasmids from yeast was described by Robzyk and Kassir (75). In the LexA system, the
plasmid containing the target and the one containing the library insert contain different E. coli origins
enabling an enrichment for the library containing plasmid by simple E. coli transformation.
Protocol 3 Preparation of DNA from yeast cells that can be re-transformed to chemical competent
bacteria
1. Use a freshly inoculated 5-10 ml culture grown overnight
2. Centrifuge 5‘, 2800 rpm
3. Resuspend in 5 ml SCE (1 M Sorbitol, 0.1 M Na3Citrate, 10 mM EDTA, pH 6.5-7, autoclaved)
4. Centrifuge 5’, 2800 rpm
5. Resuspend in 1 ml SCEM (100 ml SCE + 214 µl b - mercaptoethanol) + lyticase, transfer into 1.5
ml eppendorf
6. Incubate 1 hour at 37 °C
7. Centrifuge 5‘ at 1500 rpm
8. Remove SN carefully
9. Resuspend in 400 µl Yeast Extraction Buffer (0.05 M Tris.HCl pH 7.5, 0.025 M EDTA, 0.25 M
NaCl, 1% SDS, autoclaved)
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10. Homogenize
11. Incubate 15’ at 65 °C
12. Phenolisation using phenol/chloroform/isoamylalcohol until the interface is clear
13. Apply one extra phenolisation step using pure chloroform
14. Precipitate DNA by adding 1/10 of total volume NaAc and 2.5 volumes of icecold EtOH
15. Centrifuge 15’-30’ at 14000 rpm
16. Wash in 750 µl 70% EtOH and centrifuge 15’ at 14000 rpm
17. Dry 10’ in speedvac
18. Dissolve in 100 µl H2O
19. Transform 20 µl of this mixture to chemically competent bacteria
Insert analysis—Assay for specificity in two-hybrid
Depending on the quantity of positives obtained, several approaches can be taken. In the case of a very
limited set (<10), a new transformation with positive and negative controls (including empty vectors) to
assay the specificity of the interaction can be performed first. Between 50-100 positives, direct sequence
analysis might be considered. If more than 100 positives, they are best analyzed by colony hybridization
to identify identical inserts. Control transformations can then be done with fewer candidates. Insert
analysis might also include restriction site analysis, to identify insert families. However, new protocols
enable screening for recombinant plasmids by using PCR methods directly onto the yeast cells (40).
Much information can be derived from sequence data. By running the appropriate algorithms on the
obtained sequences, one is able to easily classify inserts into two main groups; the ones of potential
interest, and the others. The latter category includes all known genes that are not in frame with the
activation domain and those with unknown genes that show a polyAAA tail indicating that the gene is
probably inverted. Other genes that might be omitted from further analysis do not encode proteins but
RNA or retroposons. Some proteins can also be excluded if they are part of a list of known false
positives that are frequently found, independently of the target used.
Table 5: Overview of most commonly encountered false positives. Adapted from the WWW-site of E.
Golemis (44-45)
Proteins Found as false positives
Believed to date to be real
interactors
hsp's 16 5
ribosomal proteins 14 1
cytochrome oxidase 5 -
mitochondrial proteins 3 1
proteasome subunits 4 3
ferritin 4 -
tRNA synthase 3 -
collagen-related proteins 3 -
Zn finger proteins 3 4
vimentin 2 -
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In general a second more interesting category persists in the algorithmic screening, containing both
known and unknown genes. Although the choice of which interactions to characterize further is always
arbitrary, some guidelines can be used. For known proteins, the potential biological relevance of the
interaction is the most important criteria. If several clones containing portions of the same proteins are
found, one can try to establish a minimum interaction domain. By using physicochemical predictions or
three-dimensional data, the nature of interaction can be evaluated in silico, but remains to be validated
by additional biological experiments.
For new proteins that show no homology with any known sequence in DNA nor protein databases, the
above selection becomes less trivial. The redundancy at which the interaction is found might be a clue
for the importance of the interaction. Noteworthy is that this redundancy is not related to the strength of
the interaction. Even with new proteins, mostly several EST that contain parts of the coding sequence
can be found. By performing extensive EST searches, in cycle order, and using multiple sequence
alignment algorithms, one can sometimes reconstitute full-length cDNA clones. Using these sequence
data, one can perform many different algorithms to predict subcellular localization, transmembrane
domains, conserved functional patterns, etc. Of course, these predictions are never “bullet-proof”
evidence, but can be the starting point for more conclusive experiments. Apart from the false positives
that often arise, false negatives can never be excluded. Indeed a negative result in a two-hybrid system
does not necessarily mean that the two proteins tested do not interact under all conditions. Several
explanations can be given for lack of interaction (see Why not use the two-hybrid system?).
To assay the specificity of a two-hybrid interaction, a series of additional transformations is needed. In
general, these include cotransformation of the found bait with empty vector or with a vector encoding
an irrelevant protein. By using mating assays, these specificity tests can be performed in a very short
period of time. Mating takes advantage of the fact that haploid cells of the opposite mating type will
fuse to form diploids when brought into contact with each other (41). In the mating assay, the target is
expressed in one yeast strain and the activation domain fusion is expressed in a second strain of opposite
mating type. Using pre-transformed panels of yeast cells one can easily check lots of combinations that
would otherwise require long cotransfection experiments (42-44).
Take the interaction outside the yeast system
Confirmation of interaction
In general, people like to see a confirmation of the interaction outside the yeast cell. Therefore several
assays are available, such as in vitro “pull-down” assays and co-immunoprecipitation. Most of these
assays use epitope tagged versions of the proteins involved. Alternatively a co-localization experiment
can be used to validate the two-hybrid interaction couple. In most cases, interactions found in two-
hybrid can be confirmed although it may take time to find the best conditions since most of the protocols
include empirical steps that need to be optimized for every interacting couple. Probably the most
conclusive experiments are performed by co-immunoprecipitating endogeneous, and thus physiological
amounts of, proteins. A new vector, pWITCH, was designed to facilitate the characterization of proteins
encoded by novel cDNAs that were isolated using either a one- or two-hybrid assay. Expression of
directionally cloned cDNAs is obtained in vivo in Saccharomyces cerevisiae from the inducible GAL10
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promoter and in vitro from the T7 promoter. In addition, translation of the cloned cDNAs results in
proteins that are tagged in vitro with a specific epitope tag, and in vivo with both the epitope tag and the
VP16 transcription activation domain (46-47).
Functional assays to test relevance of interaction
One of the most challenging and most difficult tasks is to determine the actual function of the
interaction. The way this is achieved is largely dependent upon the signal transduction pathway in which
the interaction is thought to be functionally relevant. In most cases the effect of inhibitors, mutants or
dominant negative versions of the involved proteins can be evaluated. Using two-hybrid technology, a
very detailed but time-consuming dissection of signal transduction can be made by using the so-called
interaction suppression approach (see Interaction suppression). In almost all cases, a phenotype that can
be assayed is required. It is said that the two-hybrid is an easy tool to generate many new hypotheses.
The validation of these becomes in many cases the next time-limiting step.
NEW DEVELOPMENTS
Improvements
Refinements of vectors for use in the yeast two-hybrid system are reviewed by (48). A new host strain
was developed that is extremely sensitive to weak interactions and eliminates nearly all false positives
using simple plate assays. This yeast strain contains three reporter genes: HIS3, ADE2 and LacZ, each
under control of a different promoter (GAL1, GAL2, and GAL7 respectively) that respond to the same
activator GAL4 (76). In another system, the target protein is expressed as a fusion with the DB domain
of the human estrogen receptor (ER) in a yeast strain containing an integrated URA3 reporter gene
driven by one or three ER response elements (EREs). In contrast to the HIS3- and LEU2-based systems,
it can be assayed quantitatively, by determining the activity of the reporter gene product orotidine-5’-
monophosphate decarboxylase in cell-free extracts, and enables a negative selection scheme by using 5-
fluoroorotic acid (see Reverse Hybrid System) (49). An important advantage of this system is the use of
a target promoter that drives URA3 reporter gene expression, which is different from those commonly
used in two-hybrid systems (mostly the GAL1 promoter). Combination of this URA3/ER with
HIS3/GAL4 or LEU2/LexA might provide elegant strategies to eliminate false positives. An additional
review on progress and variations in two-hybrid and three-hybrid technologies is available (50).
Reverse Hybrid System
The two-hybrid system does not allow genetic selection of events responsible for dissociation of
particular interactions, and hence, its use in the characterization and manipulation of protein-protein
interactions has been limited. All reverse systems make use of yeast strains in which expression of
interacting hybrid proteins increases the expression of a counterselectable marker that is toxic under
particular conditions. Under these conditions, dissociation of an interaction provides a selective
advantage, thereby facilitating detection: a few growing yeast colonies in which hybrids fail to interact
can be identified among millions of non-growing colonies expressing interacting proteins. Several
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reverse hybrid systems are
proposed. The first reverse two-
hybrid system uses a yeast strain
that is resistant to cycloheximide
due to the presence of a mutant
CYH2 gene. This strain also
contains the wild-type CYH2
allele under the transcriptional
control of the GAL1 promoter.
Expression of the wild-type GAL4
protein is sufficient to restore
growth sensitivity to
cycloheximide. Growth sensitivity
towards cycloheximide is also
restored by the co-expression of
the avian c-Rel protein and its
I k B- a  counterpart, p40, as GAL4
fusion proteins. Restoration of
growth sensitivity towards
cycloheximide requires the
association of c-Rel and p40 at
the GAL1 promoter and correlates
with the ability of the c-Rel/p40
interaction to activate expression
from the GAL1 promoter (51).
Another reverse hybrid system
makes use of the most widely
used counter-selectable marker in
yeast genetics, URA3, which
encodes orotidine-5’-phosphate
decarboxylase, an enzyme
required for the biosynthesis of
uracil. Yeast cells that contain
wild-type URA3, either on a
plasmid or integrated in the
genome, grow on media lacking
uracil (URA3+ phenotype).
However, the URA3-encoded
decarboxylase can also catalyze the conversion of a non-toxic analogue, 5-fluoroorotic acid (FOA) into
a toxic product, 5-fuorouracil (52).
Figure 4: Principle of the reverse two-hybrid system. (A) the “split-hybrid”
system is based on the E. coli TN10-encoded tet-repressor (TetR)/operator
system: interaction of the hybrid proteins X and Y activates the transcription of
a TetR; the TetR protein then represses HIS3 expression, resulting in a no-
growth phenotype on plates without histidine in the growth medium (53).
Abrogation of the interaction, either by mutating Y or by introducing a
dissociator (D), shuts down TetR expression, leads to HIS3 expression and
results in growth on selective plates. (B) The reverse two-hybrid system takes
advantage of counterselectable yeast reporter genes (51,54-55). URA3
expression sensitizes yeast cells to 5-fluoroorotic acid (5-Foa), CYH2
expression to cycloheximide. Abrogation of the interaction enables the cells to
grow in the presence of these drugs.
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Hence, mutations that prevent an interaction can be selected from large libraries or randomly generated
alleles. Similarly, molecules that dissociate or prevent an interaction could be selected from large
libraries of peptides or compounds (54-55).
SRS system
A new Sos-recruitment system (SRS) was described by Aronheim (57). This SRS is based on the
observation that the mammalian GDP-GTP exchange factor (GEF) hSos can only activate Ras when
hSos is localized to the plasma membrane. In mammalian cells, this occurs by recruitment to the
cytoplasmatic tail of activated growth factor receptors. The yeast Saccharomyces cerevisiae requires a
functional Ras signaling pathway for cell viability. A yeast strain containing a point mutation in the yeast
Ras GEF (Ras guanyl nucleotide exchange factor), cdc25-2, shows temperature-sensitive growth, but
expression of hSos artificially targeted to the membrane by myristoylation or farnesylation can restore
growth at the non-permissive temperature.
The SRS uses the
requirement of
hSos to be
recruited to the
membrane to
rescue growth as
a method to
detect protein-
protein
interactions. The
target protein, is
fused to hSos,
and the partner
protein or cDNA
to be screened is
fused to a
membrane-
localization
signal. When
these hybrid
proteins are co-
expressed in a
cdc25-2 yeast strain, the cells only grow at the nonpermissive temperature if the two fusion proteins
interact, allowing the recruitment of hSos to the membrane. Mammalian Ras can bypass the requirement
for a functional Ras GEF and represents a predictable false positive in this system. In a second
publication, the author proposed that introduction of a mammalian GTPase activating protein (mGAP)
reduces the amount of false positives, thereby significantly enhancing the efficiency of the SRS system
Figure 5: Principle of the SRS system. In cells that express a chimera of Sos-X (where X is a
target protein) along with a membrane-localized version of a protein that interacts with X (cDNA),
the interaction between X and its partner recruits Sos to the plasma membrane, resulting in Ras
activation (56)
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(56). SRS may be the
method of choice in
studying interactions
that involve
transcriptional
activators or
repressors, because it is
not based on a
transcriptional readout.
In addition, certain
proteins may function
more physiologically
when expressed in the
cytoplasm rather than
the nuclear milieu. For
example, the SRS
should be more suitable
for examining
interactions between
proteins that require
modification by
cytoplasmic or
membrane-associated
enzymes.
USPS system
The ubiquitin-based
split-protein sensor
system (USPS) is based
on the fact that newly
formed fusions between
ubiquitin and proteins
are rapidly cleaved by
ubiquitin-specific
proteases in
eukaryotes.
Indeed, protein fusions
containing ubiquitin, a 76-residue single-domain protein, are rapidly cleaved in vivo by ubiquitin-specific
proteases (UBP) which recognize the folded conformation of ubiquitin. When a C-terminal fragment of
ubiquitin (Cub) is expressed as a fusion to a reporter protein, the fusion is cleaved only if an N-terminal
fragment of ubiquitin (Nub) is also expressed in the same cell. This reconstitution of native ubiquitin from
its fragments, detectable by the in vivo cleavage assay, is not observed with a mutationally altered Nub.
Figure 6: Principle underlying the ubiquitin-based split-protein system (USPS) (A) A
Ub moiety bearing an insertion (wavy red line) between its N-terminal (Nub; pink) and C-
terminal (Cub; green) subdomains is linked to a reporter protein (Re; orange, yellow). The
insertion does not detectably interfere with the Ub folding, which is required for the in vivo
cleavage of the fusion by Ub-specific proteases (UBPs; red lightning arrow), yielding the
free reporter. (B) When Nub and Cub are co-expressed as separate fragments, with Cub still
linked to the reporter, significant in vivo reconstitution is observed. (C) In vivo
reconstitution of the Ub from its separate, co-expressed fragments does not occur with a
mutant Nub fragment, denoted as Nubm. (D) Nubm supports reconstitution if the two Ub
fragments are linked to polypeptides P1 and P2 (red and blue, respectively) that interact in
vivo (58).
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However, if Cub and the altered Nub are each linked to polypeptides that interact in vivo, the cleavage of
the fusion containing Cub is restored, yielding a generally applicable assay for kinetic and equilibrium
aspects of in vivo protein interactions. This method was termed USPS which stands for ubiquitin-based
split protein sensor (58).
To higher eukaryotes: Mammalian Two-hybrid
Here the gene of interest is cloned into pM, where it is expressed as a fusion with the GAL4 DNA-BD.
The second gene is cloned into pVP16, where it is expressed as a fusion with VP16 AD. A third vector,
pG5CAT, contains the CAT reporter gene downstream of a GAL4 responsive UAS. These three vectors
are cotransfected into a mammalian cell line. Interaction between proteins X and Y is assayed by
measuring CAT gene expression by any standard method (e.g. ELISA). The system might be meaningful
to confirm interactions (59). An inverse mammalian two-hybrid system for secretase was described (60).
To determine if a protease
contained “secretase-like” activity,
a 20 amino-acid cleavage cassette
for secretase (from amyloid
precursor protein “APP”) was
inserted into the GAL4 gene of S.
cerevisiae. When this GAL4/APP
fusion construct is transiently
transfected into 293 cells and
indirectly assayed for its
functional capabilities through
chloramphenicol acetyltransferase
(CAT) transactivation, this protein
retained functional activity
confirming that no endogenous
secretase activity was present and
that the fusion protein retained its
transactivation activity. After
cotransfection of cDNAs
encoding “APP” cleaving
proteases, the ability of GAL4 to
transactivate the reporter CAT
gene was indeed reduced (60).
Three-hybrid systems
Several recent studies probed
more complex macromolecular
interactions of at least three
partners.
Figure 7: Principle of the kinase tri-brid system. The protein target needs to
be phosphorylated (P) by a co-expressed kinase before interaction occurs.
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Kinase three-hybrid system (tri-brid)
This kinase three-hybrid system called tri-brid system can detect protein-protein interactions that depend
on post translational modifications. Indeed, one of the limitations of the original version of the two-
hybrid system has been the lack of some crucial post-translational modifications (such as tyrosine
phosphorylation) which do not occur in Saccharomyces cerevisiae. Higher eukaryotic cells utilize
tyrosine phosphorylation as a major modification in signal transduction pathways in response to
extracellular stimuli. Although S. cerevisiae do possess dual-specificity kinases, to date, no mono-
specific tyrosine kinases have been
described. This was solved by
introduction of a third component, a
cytosolic tyrosine kinase, which then
phosphorylated substrates in the yeast
cell. In principle, it should be possible to
incorporate any posttranslational or
allosteric regulation that is desired.
However, care must be taken that the
posttranslational modification is
correctly carried out inside the yeast cell
(61).
Protein three-hybrid system
The protein three-hybrid system
represents a natural extension of the
two-hybrid system in that stable
interaction of proteins X and Y may rely
on the presence of a third protein Z.
Protein Z either mediates the interaction
or induces a conformational change in
one of the proteins (e.g. X) so that it
promotes interaction with another
protein Y (62). Zhang used this system
to demonstrate the Grb2-mediated
interaction of the cytoplasmic domain of
the epidermal growth factor receptor
with the Sos protein.
Recently a variant of this system was proposed by Tirode et al. (32). This system uses both LexA and
GAL4 plasmids and is based on the addition of a Met25 promoter for the third partner. This “third man”
is cloned on the same plasmid that already encodes the GAL4 and LexA fusion protein. By doing this, a
selection marker is saved. Transcription of the third protein is repressed upon addition of methionine in
the culture medium, and provides an elegant way to perform negative controls (32). In order to adapt
Figure 8: Principle that forms the basis of all multiple hybrid
systems that make use of three components at the UASG. The third
"hybrid" is colored in green.
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the two-hybrid system to the needs of caspases we devised in parallel our own three-hybrid system. This
system can be used to study any hetero-dimeric target (Figure 9)(68).
Studies with extracellular
domains of
transmembrane receptors
(10,11), have led to the
development of a peptide
ligand three-hybrid
system (63). In this
system, the extracellular
domain of a
transmembrane receptor
is fused to the GAL4BD
and separately to the
GAL4AD. Expression of
the native peptide ligand
for the receptor leads to
receptor dimerization via
peptide ligand binding
and results in a
transcriptional readout.
This was demonstrated
for both the growth
hormone receptor and
the receptor for vascular
endothelial growth factor
flk1/KDR (63).
Peptide ligand and small
ligand three-hybrid
system
The small ligand variant is based on the previously discussed concept and exploits the use of a
heterodimer of covalently linked small organic ligands, in this case dexamethasone and FK506, as
inducers of dimerization. Dexamethasone interacts with a rat glucocorticoid receptor while FK506
interacts with its binding protein, FKBP12. Yeast expressing fusion proteins of the hormone binding
domain of the rat glucocorticoid receptor fused to LexA and FKBP12 fused to a transcriptional
activation domain activated reporter genes when plated on medium containing the dexamethasone-
FK506 heterodimer. The reporter gene activation is completely abrogated in a competitive manner by
the presence of excess FK506. Since small ligand-receptor interactions underlie many fundamental
processes and form the basis for pharmacological intervention this system might gain interest. However,
limitations of the assay include those of the two-hybrid system in general and in particular the question
Figure 9: Use of three-hybrid to screen with hetero-dimeric targets. Here the target
consists of two-fusion protein (yellow and green) (68).
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of how extensively transmembrane receptors function in yeast. Since this system depends on diffusion of
the hybrid ligand into the yeast cells, permeability problems may also limit its general applicability (64).
RNA three-hybrid system
The RNA three-hybrid system requires two hybrid proteins and one hybrid RNA. One part of the hybrid
RNA acts in a known interaction, whereas the other part can be used to screen for orphan RNA-binding
proteins. In this three-hybrid system, the DNA binding and transcription activation domains of the yeast
transcriptional activator GAL4 are brought together via the interaction of recombinant fusion proteins
with a recombinant RNA. The method provides a system for studying RNA-protein interactions with the
genetic advantages of the two-hybrid system. It may be used to detect specific RNA-binding proteins or
target RNAs from a library of cDNAs, or to analyze the structural specificity of identified RNA-protein
interactions. By use of this system it was shown that when HIV-1 RevM10 is fused to the GAL4DB it
tightly binds to its target RNA, the Rev responsive element (RRE) (65). Other examples are the binding
of the iron regulatory protein
1 (IRP1) to the iron response
element (IRE), and of HIV
trans-activator protein (Tat)
to the HIV trans-activation
response element (TAR)
RNA sequence (67). This
RNA three-hybrid system
may have broad application in
the identification of RNA-
binding proteins and RNAs,
as well as in the detailed
analysis of their interactions
although it is not known how
strong the RNA-protein has
to be in order to be detected.
NEW APPLICATIONS OF
YEAST TWO-HYBRID
Introduction
During the past decade, together with the evolution of the technique, new applications became apparent.
Apart from the molecular dissection of known interactions and the identification of new potential
interacting partners, several new problems can now be assayed by use of two-hybrid based technology.
Figure 10: Reconstitution of LacZ transcription by a hybrid RNA molecule.
LexA is fused to the MS2 coat protein to form hybrid protein 1. Hybrid protein 2
consists of the GAL4AD linked to the RNA binding domain, Y, you wish to test. The
third hybrid consists of two MS2 RNA binding sites and the RNA sequence you wish
to test, RNAX.
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Interaction suppression
Interaction suppression is one of the few techniques available to evaluate the biological significance of
an interaction between two proteins. This method makes extensive use of the two-hybrid technique in a
very original manner. In a first step one screens for mutations that affect binding of a target protein to its
partners (B). Once a mutant version of the bait (A) is found, one can study the influence of this mutation
on the phenotype. However, if one finds mutants of protein A that do not interact with protein B, one
cannot exclude that also interaction with an unknown protein C is abolished and accounts for the change
in phenotype. Therefore, in a second step one has to look for binding suppressors, meaning that one
makes a mutant version of B that is able to interact with the mutated version of A and restores the
altered phenotype. This approach was taken to study the Ras/Raf pathway (69-71).
Protease Trap
Here the system relies entirely on the nuclear localization of the constructed fusion protein. A functional
transcription factor is fused to a domain preventing it from going to the nucleus. If an orphan protease
site is cloned in between the transcription factor and this domain, one can screen a protease which cuts
off the anti-nuclear localization domain enabling nuclear localization of the transcription factor and
finally results in reporter gene transcription. This approach could also be applied to screen for target
sequences for a known protease by cloning random sequences in between the two functional domains
(72). It should be noted that GAL4 may also be cleaved resulting in both unexpected results and novel
applications (73).
Whole genome approaches using the two-hybrid system
One of the most spectacular and ambitious applications consists of establishing so-called protein linkage
maps (PLM). These maps consist of all possible protein interactions that occur during the entire lifespan
of a cell. PLMs might provide new functions of well-studied proteins by identification of unexpected
interactions, clarify cross-connections between pathways, result in new drug-targets and the
identification of new functions and gain some insight in the overall cell complexity.
Initially random libraries fused to the DNA-binding domain and random activation domain hybrids are
simply used to screen for all possible interactions. This approach was applied to the E. coli
bacteriophage T7. The T7 genome of ~ 40 kb, coding for ~ 55 proteins was used to generate the two
libraries, which were then transformed into yeast strains of opposite mating type. By doing this, a total
set of interactions was identified and termed a protein linkage map. What was interesting about this
approach, apart from the biological implications of the interactions found, is that several positives were
interactions between adjacent domains of the same polypeptide. These interactions are presumably due
to the random fragmentation of protein-coding regions in the library construction, exposing interior
surfaces that are capable of finding their complementary surfaces, as must occur during protein folding
(77).
Although the genome of the yeast Saccharomyces cerevisiae is completely sequenced and despite
successful genetic work, 60% of the yeast gene have no assigned function and half of those encode
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putative proteins without any homology with known proteins. By performing exhaustive two-hybrid
screens the yeast PLM is currently under construction. For each bait, a selected limited set of interacting
preys is classified in categories of distinct heuristic values. From this classification, new baits are chosen
and used in second-round screens. Repeating this procedure several times has led to the characterization
of a network of interactions (74). The approach taken for T7, using 1 copy centromeric plasmid vector,
showed that 4% of all constructs was able to auto-activate. Scaling up this approach to an organism like
yeast with approximately 7000 proteins becomes not trivial since, false positives and negatives might
seriously interfere with subsequent analysis. Therefore, instead of using random libraries as in the above
mentioned exhaustive cyclic screening procedure, a more labor intensive route is taken by performing a
“double-PCR-in-vivo-cloning”- method in order to clone every full length ORF in the correct reading
frame in both two-hybrid vectors. Using robots and a mating procedure every possible interaction
couple, around 50 million, can be assayed (66). Defining the biological relevance of identified
interactions will be the next rate-limiting step in deciphering the molecular mechanisms of biological
processes.
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